申请人:Hoechst Marion Roussel, Inc.
公开号:US06121463A1
公开(公告)日:2000-09-19
The present invention provides compounds of the formula ##STR1## wherein R is hydrogen or --C(O)--(CH.sub.2).sub.m --Q wherein Q is hydrogen or --COOH and m is an integer 1, 2, 3 or 4; R.sub.1, R.sub.5 and R.sub.6 are independently a C.sub.1 -C.sub.6 alkyl group; R.sub.2, R.sub.3 and R.sub.4 are independently hydrogen or a C.sub.1 -C.sub.6 alkyl group; Z is thio, oxy or a methylene group; A is a C.sub.1 -C.sub.4 alkylene group; X is thio or oxy; and G.sub.1 and G.sub.2 are independently hydrogen, C.sub.1 -C.sub.6 alkyl or --C(O)--(CH.sub.2).sub.n --CH.sub.3 and n is an integer 0, 1, 2 or 3; or a pharmaceutically acceptable salt thereof; useful for the treatment of atherosclerosis and chronic inflammatory disorders; for inhibiting cytokine-induced expression of VCAM-1 and/or ICAM-1; for inhibiting the peroxidation of LDL lipid; for lowering plasma cholesterol; and as anti-oxidant chemical additives useful for preventing oxidative deterioration in organic materials.
本发明提供了以下结构的化合物:其中R为氢或--C(O)--(CH.sub.2).sub.m --Q,其中Q为氢或--COOH,m为整数1、2、3或4;R.sub.1、R.sub.5和R.sub.6分别为C.sub.1 -C.sub.6烷基基团;R.sub.2、R.sub.3和R.sub.4分别为氢或C.sub.1 -C.sub.6烷基基团;Z为硫、氧或亚甲基基团;A为C.sub.1 -C.sub.4亚烷基基团;X为硫或氧;G.sub.1和G.sub.2分别为氢、C.sub.1 -C.sub.6烷基或--C(O)--(CH.sub.2).sub.n --CH.sub.3,n为整数0、1、2或3;或其药学上可接受的盐;用于治疗动脉粥样硬化和慢性炎症性疾病;用于抑制细胞因子诱导的VCAM-1和/或ICAM-1的表达;用于抑制LDL脂质的过氧化作用;用于降低血浆胆固醇;以及作为抗氧化化学添加剂,用于防止有机材料的氧化恶化。